Advertisement

 

 

Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease.

Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease.
Author Information (click to view)

Jhun BW, Jung WJ, Hwang NY, Park HY, Jeon K, Kang ES, Koh WJ,


Jhun BW, Jung WJ, Hwang NY, Park HY, Jeon K, Kang ES, Koh WJ, (click to view)

Jhun BW, Jung WJ, Hwang NY, Park HY, Jeon K, Kang ES, Koh WJ,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

PloS one 2017 11 3012(11) e0188716 doi 10.1371/journal.pone.0188716
Abstract

Nontuberculous mycobacterial lung disease (NTM-LD) is increasingly recognized as an important predisposing condition for the development of chronic pulmonary aspergillosis (CPA), but there are limited data on the risk factors for CPA development in NTM-LD patients. We reviewed the medical records of 566 patients who, at the time of diagnosis of NTM-LD, did not have CPA and who received ≥12 months of treatment for NTM-LD between January 2010 and June 2015. Of these patients, 41 (7.2%) developed CPA (NTM-CPA group), whereas the remaining 525 patients did not develop CPA (NTM group). The median time to the development of CPA was 18.0 months from treatment initiation for NTM-LD. The NTM-CPA group was older and had significantly higher proportions of males, current smokers, and patients with a low body mass index (<18.5 kg/m2), when compared to the NTM group. Moreover, the NTM-CPA group was more likely to have a history of tuberculosis and chronic obstructive lung disease and to have used inhaled or systemic steroids. In the NTM-CPA group, more than 40% of patients had Mycobacterium abscessus complex (MABC) as the cause of NTM-LD, and the fibrocavitary form of NTM-LD was the most common; both associations were higher than in the NTM group. Overall, 17 (3%) patients died, and the NTM-CPA group had a higher mortality rate than did the NTM group (19.5% vs. 1.7%, respectively; P<0.001). In a multivariable analysis, old age, male gender, low body mass index, chronic obstructive lung disease, systemic steroids, MABC as the etiologic organism, and the fibrocavitary form of NTM-LD remained significant predictors of development of CPA. In conclusion, CPA occurred in 7.2% of patients after initiation of treatment for NTM-LD, and some risk factors were associated with CPA development. Given the worse prognosis, early diagnosis and treatment of CPA are important in patients with NTM-LD.

Submit a Comment

Your email address will not be published. Required fields are marked *

fifteen − 2 =

[ HIDE/SHOW ]